March 29, 2023 Leading by Example in Gender Diversity Among Executive Leadership Alnylam ranked #1 among MA public companies in board of directors gender diversity and #3 in executive leadership gender diversity in the 2023 WPG report.   Read More ›
March 2, 2023 Alnylam Named One of Fast Company's Most Innovative Companies for 2023 Alnylam is one of Fast Company's Most Innovative Companies for 2023, and is ranked #5 in the Medicines and Therapeutics category. Read More ›
July 13, 2022 Partnering with Nucleate to Support Young Biotech Entrepreneurs Alnylam is partnering with Nucleate to remove barriers for young biotech entrepreneurs... Read More ›
October 28, 2021 Alnylam Names Dr. Yvonne Greenstreet New CEO Dr. Yvonne Greenstreet, currently Alnylam's President and COO, has been named Alnylam's new CEO effective year-end 2021, taking over from Dr. John Maraganore. Read More ›
April 26, 2021 Diversity Equity & Inclusion at Alnylam: Building on the Momentum to Create Lasting Impact ... Sara Nochur, Alnylam's Chief Diversity, Equity & Inclusion Officer talks about DE&I at Alnylam and her role leading the company's efforts. Read More ›
December 7, 2020 Alnylam Publishes Its 1st-Ever Rare Disease Trend Report Alnylam's 2020 Rare Disease Trend Report features findings from interviews with 30 U.S. payer and plan decision-makers about barriers to orphan drug access. Read More ›
August 6, 2020 Alnylam Promotes Dr. Yvonne Greenstreet to President & COO Dr. Yvonne Greenstreet, has been elevated to the role of President of Alnylam. She will retain her COO role as well. Read More ›
June 15, 2020 Rethinking R&D to Prime it for Future Success Much of the world has this romantic notion that drug discovery involves a small numbers of hero scientists toiling away in a lab until – Eureka! Read More ›
June 9, 2020 John Maraganore in "Biotechnology in the Time of COVID-19: Commentaries from the Front Lin ... In a new e-book, dozens of biopharma industry leaders, including our CEO John Maraganore, share their perspectives from the industry's unique vantage point... Read More ›
June 7, 2020 Alnylam Leaders at BIO International Convention 2020/"Digital BIO" Even though the BIO International Convention has gone virtual for 2020 as a result of COVID-19, Alnylam leaders will continue to contribute to the... Read More ›

You are now leaving Alnylam.com

The following content may not be associated with Alnylam Pharmaceuticals.

Links to all outside sites are provided as a reference for our visitors.

Alnylam Pharmaceuticals does not endorse and is not responsible for the content on sites that are not owned and operated by Alnylam Pharmaceuticals.

Proceed to Site